SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000738
Filing Date
2024-05-10
Accepted
2024-05-10 16:16:01
Documents
55
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ckpt-20240331x10q.htm   iXBRL 10-Q 1249183
2 EX-10.1 ckpt-20240331xex10d1.htm EX-10.1 53610
3 EX-31.1 ckpt-20240331xex31d1.htm EX-31.1 15798
4 EX-31.2 ckpt-20240331xex31d2.htm EX-31.2 11282
5 EX-32.1 ckpt-20240331xex32d1.htm EX-32.1 6690
6 EX-32.2 ckpt-20240331xex32d2.htm EX-32.2 6455
  Complete submission text file 0001410578-24-000738.txt   5560954

Data Files

Seq Description Document Type Size
7 EX-101.SCH ckpt-20240331.xsd EX-101.SCH 42515
8 EX-101.CAL ckpt-20240331_cal.xml EX-101.CAL 23557
9 EX-101.DEF ckpt-20240331_def.xml EX-101.DEF 205965
10 EX-101.LAB ckpt-20240331_lab.xml EX-101.LAB 350551
11 EX-101.PRE ckpt-20240331_pre.xml EX-101.PRE 278988
59 EXTRACTED XBRL INSTANCE DOCUMENT ckpt-20240331x10q_htm.xml XML 723987
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 24935095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)